Industry News
Biotechnology Industry News
Eloxx ends long wait for phase 2 cystic fibrosis data. Market shrugs
Eloxx ends long wait for phase 2 cystic fibrosis data. Market shrugs ntaylor Wed, 11/17/2021 - 08:09
Fine-tuning targeted therapy for multiple myeloma with ‘multi-omics’ data
Fine-tuning targeted therapy for multiple myeloma with 'multi-omics' data aliu Wed, 11/17/2021 - 06:48
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea
As Merck and Pfizer predict incoming billions from their COVID drugs, Roche culls pandemic ties with Atea badams Wed, 11/17/2021 - 04:44
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners’ stock into nosedive
Novartis-partnered DARPin flames out in COVID-19 study, sending Molecular Partners' stock into nosedive ntaylor Tue, 11/16/2021 - 08:03
UPDATE: Sandrock makes a sharp exit, retiring as Biogen R&D chief amid fallout from Aduhelm approval
UPDATE: Sandrock makes a sharp exit, retiring as Biogen R&D chief amid fallout from Aduhelm approval ntaylor Tue, 11/16/2021 - 05:17
Medidata co-founder Glen de Vries dies in plane crash less than a month after Blue Origin flight
Medidata co-founder Glen de Vries dies in plane crash less than a month after Blue Origin flight aarmstrong Mon, 11/15/2021 - 11:07
Injectable ‘dancing molecules’ repair spinal cord injury, restore mobility in paralyzed mice
Injectable 'dancing molecules' repair spinal cord injury, restore mobility in paralyzed mice arlene.weintraub Mon, 11/15/2021 - 09:12
Protagonist posts phase 2 hormone replacement data, pitching for lead role in genetic iron overload disease
Protagonist posts phase 2 hormone replacement data, pitching for lead role in genetic iron overload disease ntaylor Mon, 11/15/2021 - 09:02
AHA: AstraZeneca, Moderna shine early light on mRNA potential in heart failure
AHA: AstraZeneca, Moderna shine early light on mRNA potential in heart failure badams Mon, 11/15/2021 - 09:01
Twist spins out COVID-19 antibody program, forming startup to advance variant-busting candidate
Twist spins out COVID-19 antibody program, forming startup to advance variant-busting candidate ntaylor Mon, 11/15/2021 - 08:06
SITC: Cellectis’ off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice arlene.weintraub Fri, 11/12/2021 - 10:34
UPDATED: At the eleventh hour, Woodcock shunned by Biden as Califf becomes FDA commish nominee
UPDATED: At the eleventh hour, Woodcock shunned by Biden as Califf becomes FDA commish nominee badams Fri, 11/12/2021 - 10:34
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO badams Fri, 11/12/2021 - 08:28
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares pact in latest quarterly cull
AstraZeneca wields ax, scrapping midphase programs from $1B takeover, Heptares pact in latest quarterly cull ntaylor Fri, 11/12/2021 - 06:05
Adaptimmune’s TCR T-cell therapy clears efficacy bar in rare cancers, teeing up landmark solid tumor filing
Adaptimmune's TCR T-cell therapy clears efficacy bar in rare cancers, teeing up landmark solid tumor filing ntaylor Fri, 11/12/2021 - 04:48
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease klahucik Thu, 11/11/2021 - 16:53
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut badams Thu, 11/11/2021 - 08:50
Organon keeps pedal to the metal, buying up Forendo in 3rd deal since spinning out of Merck
Organon keeps pedal to the metal, buying up Forendo in 3rd deal since spinning out of Merck ntaylor Thu, 11/11/2021 - 08:28
Genentech, Novome team up to study seaweed-controlled oral cell therapies in IBD
Genentech, Novome team up to study seaweed-controlled oral cell therapies in IBD ntaylor Thu, 11/11/2021 - 07:51
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout
After snapping up Parexel with Goldman Sachs, EQT doubles down on healthcare with Life Sciences Partners buyout badams Wed, 11/10/2021 - 08:20